Pharming Group NV(PHAR.US)

Last Updated 19:00:00 ET
longbridge loading

Pharming Group Balances Near-Term Strain With Joenja Growth

Tip Ranks·
US
PHAR
-0.36%
US
ARKG
+2.57%
US
SBIO
+1.83%
Tip Ranks·
US
PHAR
-0.36%
US
ARKG
+2.57%
US
SBIO
+1.83%

Pharming Group (OTCMKTS:PHGUF) Releases Quarterly Earnings Results

Market Beat·
US
PHAR
-0.36%
US
SBIO
+1.83%
US
IBBQ
+0.88%
Market Beat·
US
PHAR
-0.36%
US
SBIO
+1.83%
US
IBBQ
+0.88%

3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 5/8/2026

Tip Ranks·
US
IVA
+0.58%
US
PHAR
-0.36%
US
ATAI
+5.48%
Tip Ranks·
US
IVA
+0.58%
US
PHAR
-0.36%
US
ATAI
+5.48%

Pharming Group (PHAR) Gets a Buy from Canaccord Genuity

Tip Ranks·
US
PHAR
-0.36%
US
IHE
+1.08%
Tip Ranks·
US
PHAR
-0.36%
US
IHE
+1.08%

Pharming To Present New Leniolisib Pediatric And CVID Data At CIS 2026

nasdaq·
US
PHAR
-0.36%
US
IBBQ
+0.88%
US
VHT
+0.45%
nasdaq·
US
PHAR
-0.36%
US
IBBQ
+0.88%
US
VHT
+0.45%

Pharming Group shares are trading lower after the company reported worse-than-expected Q1 financial results.

benzinga_article·
US
PHAR
-0.36%
US
IBBQ
+0.88%
US
IXJ
+0.51%
benzinga_article·
US
PHAR
-0.36%
US
IBBQ
+0.88%
US
IXJ
+0.51%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga_article·
US
TRDA
+3.97%
US
AGL
+2.57%
US
ATRA
-0.21%
benzinga_article·
US
TRDA
+3.97%
US
AGL
+2.57%
US
ATRA
-0.21%

Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders | PHARM Stock News

StockTitan·
US
PHAR
-0.36%
US
IBB
+0.60%
US
XLV
+0.52%
StockTitan·
US
PHAR
-0.36%
US
IBB
+0.60%
US
XLV
+0.52%

Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026 | PHARM Stock News

StockTitan·
US
PHAR
-0.36%
US
PBE
+0.67%
US
BIB
+0.08%
StockTitan·
US
PHAR
-0.36%
US
PBE
+0.67%
US
BIB
+0.08%
© 2026 Longbridge｜Disclaimer